Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS. Abaza Y, DeZern AE. Blood 2025;145:469-474.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abaza Y, DeZern AE. Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS. Blood 2025;145:469-474.
PMID: 39541576